Browse Obstetrics/Gynecology Articles by Topic

Vaginal Cleansing at the Time of Cesarean Delivery to Prevent Puerperal Infection

Povidone-iodine (Betadine) vaginal cleansing prior to an unplanned cesarean delivery for labor-related indications did not lessen the postoperative infectious morbidity, and, therefore, its regular use in women having a cesarean delivery for labor-related indications is not supported.

Cumulative Estrogen Exposure Linked to Lower Stroke Risk

These findings could help clinicians sustain their postmenopausal patients’ neurological health.

Providing Ethical Neonatal Cardiac Care

The complexities associated with neonates with cardiac disease require a collaborative and cohesive strategy. Shared decision-making, research ethics, and outcomes reporting are important considerations.

Gaps Remain in Alcohol Use Screening Among Pregnant Patients

Despite the known benefits, it appears some clinicians still do not counsel women to avoid alcohol during pregnancy.

Probiotics and Iron Intake in Pregnancy

In a randomized controlled trial, a significantly smaller decrease in serum ferritin was observed in pregnant women with the intake of a Lactiplantibacillus plantarum 299v supplement containing a low dose of iron, folic acid, and ascorbic acid than in the placebo group.

Provider Perceptions of Neonatal Survival for Fetuses Born at 22 Weeks of Gestation

Prognostic differences exist among neonatal and obstetric care providers when neonates are delivered at 22 weeks of gestation. However, there are no statistically significant differences in the gestational age at which providers recommend active treatment or antenatal corticosteroids.

New Treatments for Uterine Fibroids

In this prospective, open-label, single-arm trial of 149 individuals with heavy menstrual bleeding and uterine leiomyomas, daily relugolix combination therapy (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) resulted in a mean menstrual blood loss reduction of 90%, and 70% of the participants achieved amenorrhea by the end of the 52-week period. Similar results were found for other arms of the trial among women who crossed over from placebo and relugolix-only therapy to relugolix combination therapy.

#IUD on TikTok: An Analysis of Intrauterine Device-Related Content on Social Media

The top 100 videos on the social media platform TikTok were compiled and systematically analyzed for user demographics and video content. More videos had a negative tone, particularly those conveying patient experiences related to pain and informed consent.

Current and Future Options for Male Contraception

Following the landmark Dobbs v. Jackson Women’s Health Organization decision that ended the constitutional right to abortion in the United States, the importance of contraception has grown. This article summarizes the existing male contraceptive options and reviews the status of future ones.

Ibrexafungerp for Vulvovaginal Candidiasis

A randomized clinical trial compared one day of oral ibrexafungerp with placebo for female patients with vulvovaginal candidiasis (VVC). It found ibrexafungerp to be safe and effective, with mild diarrhea the most common adverse event. Ibrexafungerp differs mechanistically from azoles and appears to be a promising new treatment for VVC.